Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Bellmann-Strobl

Showing results (151-160 of 173) with videos related to

Pageof 18
Sort By:
Acta Neuropathologica|November 2, 2015
Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammationAgata A Mossakowski, Julian Pohlan, Daniel Bremer, et al.
Acta Neuropathologica Communications|December 9, 2023
Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal musclesTom Aschman, Emanuel Wyler, Oliver Baum, et al.
Journal of Neuroinflammation|November 3, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcomeSven Jarius, Ingo Kleiter, Klemens Ruprecht, et al.
European Journal of Neurology|February 4, 2026
Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab-A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS)Daniel Engels, Mariella Herfurth, Joachim Havla, et al.
BMJ Neurology Open|October 24, 2025
Dyadic Coping of NMOSD and MOGAD patients and their partners: a sociological and psychological examination of strategies (CoMMOnsense-Study)Anna Walz, Daria Tkachenko, Martin W Hümmert, et al.
Neurological Research and Practice|May 5, 2026
Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disordersDaria Tkachenko, Ilya Ayzenberg, Louisa M Schöppe, et al.
Frontiers in Immunology|October 14, 2022
Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severityFranziska Sotzny, Igor Salerno Filgueiras, Claudia Kedor, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2023
Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study)Martin W Hümmert, Carlotta Stern, Friedemann Paul, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 31, 2024
Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study)Sarah Passoke, Carlotta Stern, Vivien Häußler, et al.
The Lancet. Digital Health|September 29, 2023
Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trialStefan M Gold, Tim Friede, Björn Meyer, et al.
Pageof 18

Showing results (151-160 of 173) with videos related to

Sort By:
Pageof 18
Acta Neuropathologica|November 2, 2015
Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammationAgata A Mossakowski, Julian Pohlan, Daniel Bremer, et al.
Acta Neuropathologica Communications|December 9, 2023
Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal musclesTom Aschman, Emanuel Wyler, Oliver Baum, et al.
Journal of Neuroinflammation|November 3, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcomeSven Jarius, Ingo Kleiter, Klemens Ruprecht, et al.
European Journal of Neurology|February 4, 2026
Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab-A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS)Daniel Engels, Mariella Herfurth, Joachim Havla, et al.
BMJ Neurology Open|October 24, 2025
Dyadic Coping of NMOSD and MOGAD patients and their partners: a sociological and psychological examination of strategies (CoMMOnsense-Study)Anna Walz, Daria Tkachenko, Martin W Hümmert, et al.
Neurological Research and Practice|May 5, 2026
Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disordersDaria Tkachenko, Ilya Ayzenberg, Louisa M Schöppe, et al.
Frontiers in Immunology|October 14, 2022
Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severityFranziska Sotzny, Igor Salerno Filgueiras, Claudia Kedor, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2023
Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study)Martin W Hümmert, Carlotta Stern, Friedemann Paul, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 31, 2024
Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study)Sarah Passoke, Carlotta Stern, Vivien Häußler, et al.
The Lancet. Digital Health|September 29, 2023
Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trialStefan M Gold, Tim Friede, Björn Meyer, et al.
Pageof 18